Posted on 09/21/2021 2:07:07 PM PDT by Titus-Maximus
Sept. 21 (UPI) -- Treatment with monoclonal antibodies reduced the need for hospital care in adults at high risk for serious illness from COVID-19, a study published Tuesday by JAMA Network Open found.
Just over 17% of high-risk Native Americans given the treatment based on laboratory-created antibodies, or immune proteins that fight off infections, within days of testing positive for the virus were admitted to the hospital, the data showed.
However, 43% of patients in the study who did not receive monoclonal antibodies required hospital treatment.
In addition, more than 4% of the untreated patients were admitted to a hospital intensive care unit because of COVID-19, and nearly 3% died from the disease.
None of the patients given monoclonal antibodies were admitted to the ICU and none died, they said.
Foracourt 400 double pack.
Working for me.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.